Fatty Liver and Nonalcoholic Steatohepatitis. Where Do We Stand and Where Are We Going?

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Digestive Diseases

• Publication date

  1999-09-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000016909PMID 10545713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Remission of active diabetic hepatitis after correction of hyperglycemia.

  2008cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Obesity and not alcohol intake is the main cause of liver steatosis

  1998cited by this paper
• Host- and disease-specific factors affecting steatosis in chronic hepatitis C

  1998cited by this paper
• Host- and disease-specific factors affecting steatosis in chronic hepatitis C.

  1998cited by this paper
• Prospective study of serum gamma-glutamyltransferase and risk of NIDDM.

  1998cited by this paper
• Serum Ferritin as a Component of the Insulin Resistance Syndrome

  1998cited by this paper
• Regular physical activity and coronary risk factors in Japanese men.

  1998cited by this paper
• Hepatic steatosis: Innocent bystander or guilty party?

  1998cited by this paper
• Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.

  1998cited by this paper
• The metabolically obese, normal-weight individual revisited.

  1998cited by this paper
• Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.

  1998cited by this paper
• Familial Heterozygous Hypobetalipoproteinemia, Extrahepatic Primary Malignancy, and Hepatocellular Carcinoma

  1998cited by this paper
• Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM

  1998cited by this paper
• Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty

  1998cited by this paper
• Nonalcoholic steatohepatitis.

  1997cited by this paper
• Heterozygous familial hypobetalipoproteinemia associated with fatty liver.

  1997cited by this paper
• Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets.

  1997cited by this paper
• Liver metastasis rare in colorectal cancer patients with fatty liver.

  1997cited by this paper
• Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

  1997cited by this paper
• Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population)

  1997cited by this paper
• The relationship between fatty liver and hyperinsulinemia in obese Japanese children.

  1997cited by this paper
• Insulin resistance implications for type II diabetes mellitus and coronary heart disease.

  1997cited by this paper
• A new syndrome of liver iron overload with normal transferrin saturation.

  1997cited by this paper
• Nonalcoholic fatty liver (NASH syndrome).

  1997cited by this paper
• Exercise and the metabolic syndrome

  1997cited by this paper
• REVIEW: Nonalcoholic steatohepatitis

  1997cited by this paper
• Nonalcoholic steatohepatitis.

  1997cited by this paper
• Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis

  1997cited by this paper
• Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone

  1997cited by this paper
• "Glitazones", a prospect for non-insulin-dependent diabetes.

  1997cited by this paper
• Excess weight risk factor for alcoholic liver disease

  1997cited by this paper
• The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern.

  1997cited by this paper
• Nonalcoholic Steatohepatitis

  1997cited by this paper
• Serum cholesterol and chronic hepatitis C.

  1996cited by this paper
• Three brothers with progressive hepatic dysfunction and severe hepatic steatosis due to a patent ductus venosus.

  1996cited by this paper
• Carcinogenicity of lipid-lowering drugs.

  1996cited by this paper
• Liver steatosis and chronic hepatitis C: a spurious association?

  1996cited by this paper
• Mechanism of insulin resistance and hyper-insulinemia in fatty liver.

  1996cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study

  1996cited by this paper
• Liver Steatosis and Its Relation to Plasma Haemostatic Factors in Apparently Healthy Men - Role of the Metabolic Syndrome

  1996cited by this paper
• Is non-alcoholic steatohepatitis another facet of the bright liver syndrome?

  1996cited by this paper
• Mechanism of insulin resistance and hyper-insulinemia in fatty liver.

  1996cited by this paper
• Nonalcoholic steatohepatitis.

  1996cited by this paper
• Evaluating asymptomatic patients with abnormal liver function test results.

  1996cited by this paper
• Carcinogenicity of lipid-lowering drugs.

  1996cited by this paper
• Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B.

  1996cited by this paper
• Is there any difference in coronary heart disease risk factors and prevalence of fatty liver in subjects with normal body mass index having different physiques?

  1995cited by this paper
• Non-alcoholic steatohepatitis. Report of five cases and review of the literature.

  1995cited by this paper
• Changes in Blood Lipid Composition and Response to Interferon Treatment in Chronic Hepatitis C

  1995cited by this paper
• Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people.

  1995cited by this paper
• Prevalence of fatty liver in Japanese children and relationship to obesity

  1995cited by this paper
• Idiopathic steatohepatitis in childhood: a multicenter retrospective study.

  1995cited by this paper
• [Ultrasonic and laboratory studies on fatty liver in white-collar workers].

  1995cited by this paper
• Sexually differentiated response to choline in choline deficiency and ethionine intoxication.

  1995cited by this paper
• Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM.

  1995cited by this paper
• The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.

  1995cited by this paper
• Nonalcoholic steatohepatitis and the "bright liver syndrome": should a recently expanded clinical entity be further expanded?

  1995cited by this paper
• Insulin resistance: syndrome or tendency?

  1995cited by this paper
• [Liver steatosis. I: Macrovesicular steatosis].

  1995cited by this paper
• [Liver steatosis. II: Microvesicular steatosis].

  1995cited by this paper
• Two cases from the spectrum of nonalcoholic steatohepatitis.

  1995cited by this paper
• Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes.

  1995cited by this paper
• Enteral feeding a structured lipid emulsion containing fish oil prevents the fatty liver of sepsis

  1995cited by this paper
• Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

  1995cited by this paper
• Liver disturbances in obesity and diabetes mellitus.

  1995cited by this paper
• Insulin resistance and the prevention of diabetes mellitus.

  1994cited by this paper
• Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study

  1994cited by this paper
• Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension.

  1994cited by this paper
• Serum total cholesterol and mortality in a Japanese population.

  1994cited by this paper
• [Liver steatosis assessed by ultrasonographic examination in patients with hyperlipoproteinemia].

  1994cited by this paper
• Low blood total cholesterol and mortality: causality, consequence and confounders.

  1994cited by this paper
• Relationship between Low Cholesterol and Disease

  1994cited by this paper
• Nonalcoholic steatohepatitis: an expanded clinical entity.

  1994cited by this paper
• Body fat topography as an independent predictor of fatty liver.

  1993cited by this paper
• The intestinal and liver complications of diabetes mellitus.

  1993cited by this paper
• Gastrointestinal disturbances with obesity.

  1993cited by this paper
• Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management.

  1992cited by this paper
• Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial

  1992cited by this paper
• Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

  1992cited by this paper
• Measurements of iron status in patients with chronic hepatitis.

  1992cited by this paper
• The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis

  1992cited by this paper
• Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease.

  1991cited by this paper
• Insulin resistance--mechanisms, syndromes, and implications.

  1991cited by this paper
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

  1991cited by this paper
• Pathogenesis of hepatic steatosis during total parenteral nutrition.

  1991cited by this paper
• Obesity and hepatotoxins as risk factors for fatty liver disease.

  1991cited by this paper
• Frequency of abnormalities detected by abdominal ultrasound among Japanese adults

  1991cited by this paper
• Synthetic low and high fat diets for the study of atherosclerosis in the mouse.

  1990cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• Is ethanol per se hepatotoxic?

  1990cited by this paper
• Clinical Lessons from Pathology

  1989cited by this paper
• Study on background factors associated with impaired glucose tolerance and/or diabetes mellitus.

  1989cited by this paper
• Non-A, non-B hepatitis: characterization of liver biopsy pathology.

  1989cited by this paper
• Primary nonfunction of hepatic allografts with preexisting fatty infiltration.

  1989cited by this paper
• Prevalence of fatty liver in a general population of Okinawa, Japan.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics.

  1988cited by this paper
• Comparison of Ultrasound with Liver Histology in Assessing Diffuse Parenchymal Liver Disease

  1988cited by this paper

• The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis.

  2025cites this paper
• Epidemiology of metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• Endpoints in NASH Clinical Trials: Are We Blind in One Eye?

  2024cites this paper
• Immune response and gut microbiota of mice on a diet mimicking eating habits of elderly with risk of malnutrition development

  2021cites this paper
• Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies

  2021cites this paper
• History of Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease.

  2019cites this paper
• Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome

  2018cites this paper
• Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk

  2018cites this paper
• Nonalcoholic fatty liver disease: Evolving paradigms

  2017cites this paper
• Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto.

  2016cites this paper
• Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis

  2015cites this paper
• Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

  2015cites this paper
• Review Article Conventional Drugs and Herbal Medicines Showing Hepatotoxicity: A Review

  2015cites this paper
• Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

  2015cites this paper
• Benefic Interactive Effects between Garlic Consumption and Serum Iron Excess

  2014cites this paper
• Prevalence of Non-Alcoholic Fatty Liver among Adults in Khartoum- Sudan: Epidemiological Survey

  2013cites this paper
• Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.

  2013cites this paper
• Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells.

  2013cites this paper
• The relationship between copper and steatosis in Wilson's disease.

  2013cites this paper
• Diabetes and Liver Disease: Are There Evidences for a Close Association and Is It Worth Investigating?

  2012cites this paper
• Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease

  2011cites this paper
• Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?

  2011cites this paper
• Biochemical and histological liver changes occurred after iron supplementation and possible remediation by garlic consumption

  2011cites this paper
• Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease

  2010cites this paper
• Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels

  2009cites this paper
• Clinical, biochemical and histological characteristics of a Sri Lankan population of non-alcoholic steatohepatitis (NASH) patients.

  2009cites this paper
• Nonalcoholic fatty liver disease: from clinical recognition to treatment

  2008cites this paper
• Frequency of abnormalities detected by upper abdominal ultrasound.

  2008cites this paper
• Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of Three Cases

  2007cites this paper
• The Association of Fatty Liver and Diabetes Risk

  2007cites this paper
• The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome

  2007cites this paper
• Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.

  2007cites this paper
• Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults

  2006cites this paper
• Elaziğ kent toplumunda nonalkolik yağli karaciğerin epidemiyolojik özellikleri

  2006cites this paper
• Hepatic steatosis and insulin resistance: does etiology make a difference?

  2006cites this paper
• 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.

  2006cites this paper
• PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE

  2006cites this paper
• Steatosi associata al virus dell'epatite C e steatosi metabolica. Patologie diverse o sovrapposte?

  2005cites this paper
• Should Nonalcoholic Fatty Liver Disease Be Renamed?

  2005cites this paper
• Mechanisms of liver regeneration and their clinical implications.

  2005cites this paper
• Review article: hepatic steatosis and insulin resistance

  2005cites this paper
• Histological characteristics and prognosis in patients with fatty liver

  2005cites this paper
• CONVENTIONAL DRUGS AND HERBAL MEDICINES-INDUCED HEPATOTOXICITY

  2005cites this paper
• Patologie diverse o sovrapposte ?

  2005cites this paper
• 36 – Epidemiology and Risk Factors Involved in Alcoholic Liver Disease

  2004cites this paper
• Long term prognosis of fatty liver: risk of chronic liver disease and death

  2004cites this paper
• Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease.

  2004cites this paper
• The wide spectrum of steatohepatitis: a report of four cases and a review of the literature

  2004cites this paper
• They could have named it "bupopion".

  2003cites this paper
• [Nonalcoholic steatohepatitis--a "new" hepatic disease].

  2003cites this paper
• Nichtalkoholische Leberverfettungen und Steatohepatitiden

  2003cites this paper
• Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics.

  2003cites this paper
• Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

  2003cites this paper
• Olanzapine/risperidone and diabetes risk.

  2003cites this paper
• Evidence that eicosapentaenoic acid is effective in treating autism.

  2003cites this paper
• Clozapine and pregnancy.

  2003cites this paper
• NONALCOHOLIC STEATOHEPATITIS AND INSULIN RESISTANCE : INTERFACE BETWEEN GASTROENTEROLOGISTS AND ENDOCRINOLOGISTS

  2003cites this paper
• Risk of Cancer in Patients Hospitalized With Fatty Liver: A Danish Cohort Study

  2003cites this paper
• Carbamazepine treatment of adverse psychiatric effects after treatment with the nonsteroidal anti-inflammatory drug piroxicam.

  2003cites this paper
• EVALUATION OF THE IMMUNE RESPONSE TO PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES

  2003cites this paper
• Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.

  2003cites this paper
• AGA technical review on nonalcoholic fatty liver disease.

  2002cites this paper
• Is insulin resistance a pathogenic co-factor in hepatitis C virus-related disease and hepatocellular carcinoma?

  2002cites this paper
• Apolipoprotein synthesis in nonalcoholic steatohepatitis

  2002cites this paper
• Hepatic steatosis and type 2 diabetes mellitus

  2002cites this paper
• Obesity and liver disease.

  2002cites this paper
• Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults

  2002cites this paper
• Epidemiology of Fatty Liver in a Hospital-based Study in Taiwan

  2002cites this paper
• Replication of linkage of familial hypobetalipoproteinemia to chromosome 3p in six kindreds.

  2002cites this paper
• Of liver, whisky and plants: a requiem for colchicine in alcoholic cirrhosis?

  2002cites this paper
• Liver Regeneration Is Not Altered in Patients with Nonalcoholic Steatohepatitis (NASH) When Compared to Chronic Hepatitis C Infection with Similar Grade of Inflammation

  2002cites this paper
• The Clinicopathologic Spectrum and Management of Nonalcoholic Fatty Liver Disease

  2002cites this paper
• Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study.

  2002cites this paper
• Reply

  2002cites this paper
• Growth hormone plasma levels in nonalcoholic fatty liver disease

  2002cites this paper
• Alcoholic and nonalcoholic steatohepatitis.

  2002cites this paper
• Enalapril prevents fatty liver in nephrotic rats.

  2002cites this paper
• Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study.

  2001cites this paper
• Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene.

  2001cites this paper
• Nichtalkoholische Steatohepatitis (NASH)

  2001cites this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cites this paper
• Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

  2001cites this paper
• [Fatty liver].

  2000cites this paper
• Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution

  2000cites this paper
• A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5).

  2000cites this paper
• Lai

  1998cites this paper